India: The Emerging Global Clinical Trial Hub

India is rapidly transforming into one of the world’s most attractive destinations for clinical research and drug development. With a population exceeding 1.4 billion, a diverse genetic pool, highly qualified investigators, cost-efficient operations, and a progressively evolving regulatory environment, India is increasingly being recognized as a strategic hub for global clinical trials. The India clinical trials market was valued at USD 1.42 billion in 2024 and is expected to grow at a CAGR of 8.0% from 2025 to 2030, driven by the expanding pharmaceutical and biotechnology sectors.

Read more